Preclinical biomarkers of parkinson disease

Keyphrases

• Parkinson's Disease 100%
• Clinical Biomarkers 100%
• Preclinical Parkinson's Disease 66%
• Neurodegeneration 33%
• Early Detection 33%
• Signaling Pathway 33%
• Differential Diagnosis 33%
• Disease Onset 33%
• Neuropathology 33%
• Neuroimaging 33%
• High-risk Population 33%
• Metabolomics 33%
• Early Signs 33%
• Progressive Neurodegeneration 33%
• Parkinsonian Disorders 33%
• Clinical Onset 33%
• Computational Proteomics 33%
• Technology Identification 33%
• Early Symptoms 33%
• Neuroprotective Strategies 33%
• Basic Neuroscience 33%
• Lipidomics 33%
• Systems Biology Tools 33%
• Monitoring Disease Progression 33%
• Clinical Recognition 33%

Medicine and Dentistry

• Parkinson's Disease 100%
• Biological Marker 100%
• Neurodegeneration 40%
• Diseases 20%
• Differential Diagnosis 20%
• Disease Exacerbation 20%
• Physical Disease by Body Function 20%
• Cell Signaling Pathway 20%
• Proteomics 20%
• Neuroprotective Agent 20%
• Translating (Language) 20%
• Parkinsonism 20%
• Metabolomics 20%
• Transcriptomics 20%
• High-Risk Population 20%
• Lipidomics 20%

Neuroscience

• Parkinson's Disease 100%
• Neurodegeneration 40%
• Neuroscience 20%
• Neuroprotective Agent 20%
• Parkinsonism 20%
• Transcriptomics 20%
• Differential Diagnosis 20%
• Proteomics 20%